These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 759178)

  • 1. [Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
    Angelkort B; Stürner KH
    Dtsch Med Wochenschr; 1979 Feb; 104(5):182-6. PubMed ID: 759178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor.
    Chuansumrit A; Isarangkura P; Krutvecho T; Hathirat P; Pintadit P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():139-43. PubMed ID: 2499649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
    Klare M
    Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postpartum hemophilia A with factor VIII inhibitor].
    Neidhardt B; Bartels O; Hahn B
    Dtsch Med Wochenschr; 1985 May; 110(20):799-802. PubMed ID: 3922727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the cell-separator in the treatment of factor-VIII-inhibitor hemophilia].
    Piller G; Druml W; Höcker P; Niessner H; Rainer H; Lechner K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1654-9. PubMed ID: 1030071
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acquired haemophilia A].
    Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ
    Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Exchange transfusion in the treatment of the hemophilic child with factor VIII inhibitors].
    Benítez-Aranda H; Farfán Canto JM; Esparza-Flores MA; Bernaldez-Ríos R; Alvarez-Amaya C
    Bol Med Hosp Infant Mex; 1985 Nov; 42(11):687-91. PubMed ID: 3936511
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphospholipid syndrome and resistance to replacement therapy in hemophilia].
    Barkagan ZS; Serdiuk GV; Golubenko VN
    Klin Med (Mosk); 1992 Feb; 70(2):42-4. PubMed ID: 1507818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bleeding in haemophilia during massive treatment with anti-haemophilic globulin (author's transl)].
    Sutor AH; Jesdinsky-Buscher C
    Dtsch Med Wochenschr; 1975 May; 100(21):1183-6. PubMed ID: 1132328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
    Rasche H; Bindewald H; Köhle W; Scheck R; Heinrich R; Seibert K
    Dtsch Med Wochenschr; 1977 Mar; 102(9):319-23. PubMed ID: 300053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 17. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorrhagic syndrome associated with a factor VIII:C inhibitor in a patient with lymphoma].
    Casas E; García Puig J; Villar A; González Sanz A; Miranda ME; Ortiz Vázquez J
    Med Clin (Barc); 1989 Jun; 93(1):23-5. PubMed ID: 2505004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.